Skip to content
Menu
Breaking Efficacy Ceilings
Home
About
Science
Pipeline
News
Careers
Triveni Bio
News
The latest company updates, news, and insights
BioPharmaDive News: With $115M more, Triveni accelerates immune drug work
In the News
10.2.2024
FierceBiotech News: Triveni ropes in $115M series B less than a year after $92M fundraise
In the News
10.2.2024
Stifel 2024 Virtual Immunology and Inflammation Summit
In the News
9.18.2024
MedCity News: Biotech Startup Triveni Unveils $92M to Address Barrier to Treating Inflammation
In the News
11.5.2023
BioPharma Dive: Triveni emerges from biotech merger with $92M for immune disease drugs
In the News
10.26.2023
Top
